Ulteriori informazioni
Informationen zum Autor Gary H Lyman: Co-Director, Hutchinson Institute for Cancer Outcomes Research; Affiliate Professor, University of Washington Schools of Public Health and Pharmacy, Seattle, WA Klappentext The Oxford American Handbook of Oncology is the essential ready reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated for the new edition. Zusammenfassung The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout. Inhaltsverzeichnis Part 1 Background 1 Molecular cancer biology 2 Etiology and epidemiology Part 2 Cancer prevention and screening 3 Cancer prevention 4 Cancer screening 5 Genetic screening Part 3 Principles of management 6 Principles of cancer treatment 7 Surgical oncology 8 Principles of radiation oncology 9 Principles of chemotherapy 10 Hematopoietic stem cell transplantation 11 Hormone therapy 12 Targeted therapies 13 Gene therapy and immunotherapy for cancer 14 Complementary and alternative medicine 15 Clinical trials Part 4 Complications and supportive care 16 Anemia and fatigue 17 Febrile neutropenia 18 Pain management 19 Venous thromboembolism 20 Metabolic emergencies 21 Paraneoplastic syndromes 22 Superior vena cava syndrome and raised intracranial pressure 23 Spinal cord compression 24 Other obstructive complications 25 Late effects of cancer treatment 26 End-of-life care Part 5 Specific cancers 27 Thoracic cancers 28 Breast cancer 29 Gastrointestinal cancer I: esophagus, stomach, small intestine, carcinoid 30 Gastrointestinal cancer II: pancreas, biliary tract, hepatocellular 31 Gastrointestinal cancer III: colorectal, anus 32 Endocrine cancers 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas 34 Genitourinary cancer II: prostate cancer 35 Genitourinary cancer III: testicular cancer 36 Gynecological cancer 37 Tumors of the central nervous system 38 Head and neck cancers 39 Cutaneous malignancies 40 Soft tissue and bone sarcomas 41 Acute leukemia 42 Chronic leukemias and myelodysplastic syndromes 43 Multiple myeloma 44 Malignant lymphoma 45 Cancer of unknown primary (CUP) Appendix ...
